Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Blood|April 26, 2024
Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantationClara Philine Wienecke, Bennet Heida, Letizia Venturini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 27, 2023
Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis RegisterRyan M Hum, Seema D Sharma, Michael Stadler, et al.
Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.
Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.
Human Gene Therapy|November 25, 2010
Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantationSylvia Borchers, Elena Provasi, Anna Silvani, et al.
The Journal of Pathology. Clinical Research|February 1, 2017
Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantationDanny Jonigk, Berenice Rath, Paul Borchert, et al.
Cancers|August 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AMLKatrin Teich, Michael Stadler, Razif Gabdoulline, et al.
Plos One|December 29, 2012
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantationSylvia Borchers, Melanie Bremm, Thomas Lehrnbecher, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2026
A Phase 1 Trial of Dose-Escalated Hypofractionated Adaptive Radiation Therapy With Atezolizumab for Advanced Head and Neck CancersMusaddiq Awan, Sergey Tarima, Joseph Zenga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host DiseaseDaniel Wolff, Michael Schleuning, Stephanie von Harsdorf, et al.
Pageof 17